Zacks.com on MSN3d
GSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract Infection
The FDA approval is based on late-stage data, which shows that GSK's Blujepa is at least as effective as a leading standard treatment for uncomplicated UTIs.
FDA Approves GSK's Oral Antibiotic For Urinary Tract Infections For Females Aged 12 Years And Older
The FDA approved GSK's Blujepa for uncomplicated UTIs in female adults and pediatric patients, with phase 3 trials showing strong efficacy vs. nitrofurantoin.
pharmaphorum2d
GSK ends decades-long hiatus in oral antibiotics for UTIs
Primary care studies have suggested a worldwide ... as an intramuscular injection of ceftriaxone and oral azithromycin in the EAGLE-1 trial. GSK is one of the few remaining big pharma companies ...
Fierce Pharma4d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
PMLive2d
GSK’s antibiotic Blujepa granted FDA approval to treat urinary tract infections
GSK’s oral antibiotic Blujepa (gepotidacin) has been approved by the US Food and Drug Administration (FDA) to treat ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
Nasdaq3d
GSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract Infection
GSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for ... a leading standard-of-care (SOC) therapy for uUTIs. In EAGLE-2, the drug met its primary goal of non ...
Contract Pharma3d
GSK’s Blujepa Approved by FDA for Treatment of uUTIs
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...